Institutional Biosafety Committee
The TCU Institutional Biosafety Committee (IBC), appointed by the Chancellor, is the
institutional body responsible for oversight of activities involving biohazardous
agents and recombinant and synthetic nucleic acid molecules that require approval
for "biosafety activities" as described in governmental regulatory requirements. These
regulatory requirements include, but are not limited to, the National Institutes of Health Guidelines for Research Involving Recombinant or Synthetic
Nucleic Acid Molecules, the Centers for Disease Control (CDC) and Prevention Guidelines, select agents and toxins regulated by the Department of Health and Human Services, and the CDC's advisory document, Biosafety in Microbiological and Biomedical Laboratories, recommending best practices for the safe conduct of work in biomedical and clinical
laboratories.
The composition of the Institutional Biosafety Committee meets the requirements as
specified in the NIH Guidelines and includes two community members who are not affiliated
with TCU. IBC Members
The IBC oversees TCU's Biosafety in Research program which includes assessing biosafety containment level and other potential biologics. For additional information, review the Office of Research biosafety site or contact the Office of Research at research@tcu.edu.
Resources & Forms
NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules
Department of Health and Human Services - Select Agents and Toxins
U.S. Department of Agriculture - Select Agents and Toxins
Centers for Disease Control and Prevention - Biosafety in Microbiological and Biomedical
Laboratories
Training
Prior to beginning work with biohazardous material, all personnel must complete the
relevant training. Review the IBC Training webpage for additional information.